tiprankstipranks
Trending News
More News >
Eterna Therapeutics Inc. (ERNA)
:ERNA
US Market
Advertisement

Eterna Therapeutics (ERNA) Income Statement

Compare
265 Followers

Eterna Therapeutics Income Statement

Last quarter (Q1 2025), Eterna Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Eterna Therapeutics's net income was $-8.20M. See Eterna Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 582.00K$ 68.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 486.00K$ -168.00K$ -497.00K$ -459.00K$ -98.00K
Operating Expenses
$ 16.16M$ 20.97M$ 26.45M$ 26.97M$ 7.15M
Depreciation and Amortization
$ 1.64M$ 1.12M$ 497.00K$ 459.00K$ 98.00K
EBITDA
$ -36.12M$ -19.93M$ -24.01M$ -121.95M$ -26.39M
Operating Income
$ -15.67M$ -21.14M$ -26.95M$ -27.43M$ -7.25M
Other Income/Expenses
$ -28.84M$ -536.00K$ 2.41M$ -95.05M$ -19.28M
Pretax Income
$ -44.51M$ -21.67M$ -24.53M$ -122.30M$ -26.53M
Net Income
$ -44.54M$ -21.67M$ -24.58M$ -122.31M$ 11.91M
Per Share Metrics
Basic EPS
$ -1.57$ -4.08$ -8.06$ -56.61$ -3.51
Diluted EPS
$ -1.57$ -4.08$ -8.06$ -56.61$ -3.51
Weighted Average Shares Outstanding
28.40M 5.31M 3.05M 2.17M 1.73M
Weighted Average Shares Outstanding (Diluted)
28.40M 5.31M 3.05M 2.17M 1.73M
Currency in USD

Eterna Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis